NCT00220753

Brief Summary

The purpose is to find out if Icleen IQAir, HEPA-filter air cleaners with high capacity and pre-set speed functions, have a beneficial effect on patients with asthma and allergy to dogs. Air cleaners will be installed in the bedrooms and living rooms in the homes of children and adolescents aged 8-17 years at the study entry, with allergy to dogs, but not to house dust mites. The investigators will look upon the significance of this study, and of a previous study with a similar design and the same main parameters to find out if this trial supports the results of the first trial by the same project leader, or makes it likely that the seemingly beneficial effects of the first study occurred by chance. Main parameters:

  • hyperventilation cold air challenge test Supportive parameters:
  • serum ECP
  • symptom scores The trial will be a parallel, double blind placebo controlled one.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable asthma

Timeline
Completed

Started Sep 2005

Shorter than P25 for not_applicable asthma

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2005

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

September 19, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 22, 2005

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2006

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2006

Completed
Last Updated

July 23, 2009

Status Verified

July 1, 2009

Enrollment Period

5 months

First QC Date

September 19, 2005

Last Update Submit

July 21, 2009

Conditions

Keywords

Dog allergyPet allergyAir cleanersHEPA filtersAir filtrationCan f1AsthmaChildrenAdolescentsIndoor environmentIndoor allergyPerennial allergy

Outcome Measures

Primary Outcomes (1)

  • Bronchial hyperactivity by cold air hyperventilation

    September 2005 - February 2006

Secondary Outcomes (3)

  • Serum ECP

    September 2005- February 2006

  • Asthma symptom score

    September 2005 - February 2006

  • Allergic rhinitis symptom score

    September 2005 - February 2006

Study Arms (2)

Active air cleaner

ACTIVE COMPARATOR

Two Icleen IQAir air cleaners with active filters supplied

Device: IQAir Allergen 100 Air cleaners

Placebo air cleaner

PLACEBO COMPARATOR

Two Icleen IQAir air cleaners with placebo filters supplied

Device: IQAir Allergen 100 Air cleaners

Interventions

Two air cleaners are installed in the patient's room, one in his bedroom, and one in the living room. The cleaners can be run at 5 different speeds: Speed 1 filtrates 60m3 of air per hour, speed 2 filtrates 90 m3 per hour, speed 3 filtrates 130 m3 per hour, speed 4 filtrates 240 m3 per hour, and speed 5 filtrates 380 m3 per hour. A timer-on period can be pre-set for every day of the week, but the cleaner can be run even in the timer-off period, at a speed pre-set and different from the timer-on period. Different timer-on off periods cannot be selected for different days, but the different days of the week can be pre-set to apply timer-on periods or not.

Also known as: Health Pro
Active air cleanerPlacebo air cleaner

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children and adolescents between 8 and 17 years of age at the start of the trial (born after 01 March '88, but before 01 September '97).
  • Bronchial asthma, diagnosed by a physician, and confirmed by a physician at a paediatric department of a Norwegian Hospital.
  • Allergy against dogs, confirmed by skin prick test. Average infiltrate at least 4 millimetres against dog, diagnosed by a new skin prick test at entry. For details about skin prick test, see attachment no. 6.
  • Having had nose or breathing symptoms by contact with dogs, when no drugs against asthma or allergy have been taken.
  • Able to co-operate at cold air hyperventilation test and spirometry (see attachment no. 2).
  • Given written consent (by parents of children below 12; by parents and child when above 12, but below 16; by patient when above 16).

You may not qualify if:

  • Positive house dust mite skin prick test, with a more than 3 mm infiltrate.
  • Having taken oral beta-2-agonists or theophylline preparations for the last 2 weeks before trial start, or oral steroids for the last 3 months before start of the trial.
  • Active smoking.
  • Dogs or cats in the home.
  • Staying away from the home continuously for more than 14 days in the trial period or during the last month before trial start.
  • Being an in-patient in a special department or institution for asthma and allergy in the trial period or the last 3 months before the trial.
  • Having another chronic disease that can influence the results of ECP or cold air hyperreactivity tests.
  • Other types of mechanical ventilation or air filtration systems in the homes, except for those for kitchen stoves.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Barnepoliklinikken, Sykehuset Innlandet HF

Hamar, N-2326, Norway

Location

Related Publications (9)

  • Green R, Simpson A, Custovic A, Faragher B, Chapman M, Woodcock A. The effect of air filtration on airborne dog allergen. Allergy. 1999 May;54(5):484-8. doi: 10.1034/j.1398-9995.1999.00029.x.

    PMID: 10380780BACKGROUND
  • van der Heide S, van Aalderen WM, Kauffman HF, Dubois AE, de Monchy JG. Clinical effects of air cleaners in homes of asthmatic children sensitized to pet allergens. J Allergy Clin Immunol. 1999 Aug;104(2 Pt 1):447-51. doi: 10.1016/s0091-6749(99)70391-x.

    PMID: 10452769BACKGROUND
  • Wood RA. Air filtration devices in the control of indoor allergens. Curr Allergy Asthma Rep. 2002 Sep;2(5):397-400. doi: 10.1007/s11882-002-0073-3.

    PMID: 12165206BACKGROUND
  • McDonald E, Cook D, Newman T, Griffith L, Cox G, Guyatt G. Effect of air filtration systems on asthma: a systematic review of randomized trials. Chest. 2002 Nov;122(5):1535-42. doi: 10.1378/chest.122.5.1535.

    PMID: 12426250BACKGROUND
  • Gore RB, Bishop S, Durrell B, Curbishley L, Woodcock A, Custovic A. Air filtration units in homes with cats: can they reduce personal exposure to cat allergen? Clin Exp Allergy. 2003 Jun;33(6):765-9. doi: 10.1046/j.1365-2222.2003.01678.x.

    PMID: 12801310BACKGROUND
  • Simpson A, Simpson B, Custovic A, Craven M, Woodcock A. Stringent environmental control in pregnancy and early life: the long-term effects on mite, cat and dog allergen. Clin Exp Allergy. 2003 Sep;33(9):1183-9. doi: 10.1046/j.1365-2745.2003.01679.x.

    PMID: 12956752BACKGROUND
  • Woodcock A, Lowe LA, Murray CS, Simpson BM, Pipis SD, Kissen P, Simpson A, Custovic A; NAC Manchester Asthma and Allergy Study Group. Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years. Am J Respir Crit Care Med. 2004 Aug 15;170(4):433-9. doi: 10.1164/rccm.200401-083OC. Epub 2004 May 13.

    PMID: 15142868BACKGROUND
  • Lowe LA, Woodcock A, Murray CS, Morris J, Simpson A, Custovic A. Lung function at age 3 years: effect of pet ownership and exposure to indoor allergens. Arch Pediatr Adolesc Med. 2004 Oct;158(10):996-1001. doi: 10.1001/archpedi.158.10.996.

    PMID: 15466689BACKGROUND
  • Arbes SJ Jr, Cohn RD, Yin M, Muilenberg ML, Friedman W, Zeldin DC. Dog allergen (Can f 1) and cat allergen (Fel d 1) in US homes: results from the National Survey of Lead and Allergens in Housing. J Allergy Clin Immunol. 2004 Jul;114(1):111-7. doi: 10.1016/j.jaci.2004.04.036.

    PMID: 15241352BACKGROUND

MeSH Terms

Conditions

AsthmaHypersensitivity

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateImmune System Diseases

Study Officials

  • Leif B. Rolfsjord, M.D.

    Sykehuset Innlandet HF

    PRINCIPAL INVESTIGATOR
  • Leiv Sandvik, PhD

    Oslo Universitetssykehus Ulleval

    STUDY CHAIR
  • Ragnhild Halvorsen, M.D., Ph.D.

    Oslo Universitetssykehus Rikshospitalet

    STUDY CHAIR
  • Sten Dreborg, M.D., Ph.D.

    Alingsåsv. 11, S-443 35 Lerum, Sweden

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 19, 2005

First Posted

September 22, 2005

Study Start

September 1, 2005

Primary Completion

February 1, 2006

Study Completion

April 1, 2006

Last Updated

July 23, 2009

Record last verified: 2009-07

Locations